Google
Trusted Resources: Community Center
Online groups, photo galleries and blogs
Hope & Destiny: The Patient and Parent’s Guide to Sickle Cell Disease and Sickle Cell Trait
Sickle Cell Disease is the most common blood disorder in the U.S. Hope & Destiny provides clear-cut and in-depth information for the more than 80,000 Americans living with sickle cell disease. Written especially for parents and caregivers, it offers the latest information on preventing complications, research, and treatment. The knowledge patients and family members need is organized in an easy-to-read format that promotes overall healthy living.
+myBinderRelated Content
-
Gene Therapy: An Experimental Technique to Treat Genetic DiseasesGene therapy is an experimental techniqu...
-
Sickle Cell Trait and Risk of Cognitive Impairment in African-Americans: The Regards CohortBackground: Sickle cell anemia may be ...
-
A Britain’s Got Talent contestant revealed how she turned to singing following the death of her sonA Britain's Got Talent contestant whose ...
-
Sending a Child With Sickle Cell Disease off to CollegeSickle cell disease afflicts about 100,0...
-
Pediatric sickle cell study stopped early due to positive resultsA national sickle cell disease study inv...
-
FDA Approves First Targeted Therapy to Treat Patients with Painful Complication of Sickle Cell DiseaseToday, the U.S. Food and Drug Administra...
-
Robert I. Liem, MD, MSRobert I. Liem is Associate Professor of...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
